1. Activision Blizzard
Stock gain this year: 96%
Openfolio users who own it: 1.6%
Video games ruled in 2015. Activision (, Tech30) — led by sales of its signature game “Call of Duty” — beat Wall Street expectations by a mile this year. It also acquired King Digital, the maker of Candy Crush, for $5.9 billion in November.
Stock gain this year: 67%
Openfolio users who own it: 1%
Nvidia (, Tech30) may not be one of the best known stocks, but its rubbing shoulders with one. A computer, tablet and smartphone chip manufacturer, Nvidia is also leading the market for in-car infotainment systems. One of its key partners: Tesla.
Like other overlooked stocks, Nvidia also makes video games.
3. Electronic Arts
Stock gain this year: 48%
Openfolio users who own it: 0.8%
The No. 1 video games publisher for Xbox and PlayStation 4, Electronic Arts (Tech30)’ stock hit an all-time high this year. In addition to its flagship games like Madden NFL, EA is raking in extra profits this fall from its new Star Wars Battlefront video game.,
Stock gain this year: 46%
Openfolio users who own it: 1.4%
JetBlue () is having a moment. Its passenger volume is up 11% so far this year compared to last, and like other airlines, it’s benefiting from low fuel prices. Its number of departures is up by double digits too. JetBlue stands to profit more in 2016 as it beefs up its commercial flights to Cuba.
Stock gain this year: 34%
Openfolio users who own it: 2.6%
What global economic slowdown? Nike sells lots of its sneakers and jerseys overseas, but the headwinds abroad haven’t stopped its stock from having another All-Star year. The company is also profiting from a lower tax rate this year. Nike recently announced its tax rate this year is 19.1% compared with 25.4% a year ago. The tax cut is due to its increased international business.
Nike (), which makes more abroad than in North America, is still raking in cash too. In its most recent quarter it made $7.7 billion, up 4% from a year ago.
Stock gain this year: 22%
Openfolio users who own it: 0.9%
Allergan () epitomizes how many companies sought to find profits in a year hit by a sluggish global economy: mergers. Allergan merged with Pfizer in the biggest pharmaceutical deal ever, valued at $160 billion. Allergan, the maker of Botox, saw its stock shoot up after the deal was announced.